A functional nuclear epidermal growth factor receptor, Src and Stat3 heteromeric complex in pancreatic cancer cells

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Jaganathan, Soumya ^a   Yue, Peibin ^a   Paladino, David C ^a   Bogdanovic, Jelena ^b   Huo, Qun ^b   Turkson, James ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MYC PROTEIN; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; STAT3 PROTEIN; EGFR PROTEIN, HUMAN; MULTIPROTEIN COMPLEX; NANOPARTICLE; PROTEIN KINASE P60; STAT3 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INDUCTION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PANCREAS CANCER; PHENOTYPE; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; CELL NUCLEUS; CONFOCAL MICROSCOPY; ENDOCYTOSIS; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIGHT; METABOLISM; NANOTECHNOLOGY; PANCREAS TUMOR; PARTICLE SIZE; PATHOLOGY; PROTEIN BINDING; RADIATION SCATTERING; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; ENDOCYTOSIS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIGHT; MICROSCOPY, CONFOCAL; MULTIPROTEIN COMPLEXES; NANOPARTICLES; NANOTECHNOLOGY; PANCREATIC NEOPLASMS; PARTICLE SIZE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTOR, EPIDERMAL GROWTH FACTOR; SCATTERING, RADIATION; STAT3 TRANSCRIPTION FACTOR;

EID: 79955799333     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019605     Document Type: TB

References (51)

1. Ulrich A, Schlessinger J, (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212.
2. Schlessinger J, (2000) Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
3. Darnell JE, (2005) Validating Stat3 in cancer therapy. Nat Med 11: 595-596.
4. Liu L, McBride KM, Reich NC, (2005) STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. Proc Natl Acad Sci USA 102: 8150-8155.
5. Kawashima T, Bao YC, Minoshima Y, Nomura Y, Hatori T, et al. (2009) A Rac GTPase-activating protein, MgcRacGAP, is a nuclear localizing signal-containing nuclear chaperone in the activation of STAT transcription factors. Mol Cell Biol 29: 1796-1813.
6. Bild AH, Turkson J, Jove R, (2002) Cytoplasmic transport of Stat3 by receptor-mediated endocytosis. Embo J 21: 3255-3263.
7. Sehgal PB, Guo GG, Shah M, Kumar V, Patel K, (2002) Cytokine signaling: STATS in plasma membrane rafts. J Biol Chem 277: 12067-12074.
8. Lo HW, Hsu SC, Hung MC, (2006) EGFR signaling pathway in breast cancer: from traditional signal transduction to direct nuclear translocation. Breast Cancer Res Treat 95: 211-218.
9. Lin SY, Makino K, Xia W, Matin A, Wen Y, et al. (2001) Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3: 802-808.
10. Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia W, et al. (2005) Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7: 575-589.
11. Korc M, Meltzer P, Trent J, (1986) Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. Proc Natl Acad Sci U S A 83: 5141-5144.
12. Trevion JG, Summy JM, Lesslie DP, Parikh NU, Hong DS, et al. (2006) Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol 168: 962-972.
13. Trevino JG, Gray MJ, Nawrocki ST, Summy JM, Lesslie DP, et al. (2006) Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells. Angiogenesis 9: 101-110.
14. Scholz ASH, Detjen KM, Peters M, Welzel M, Hauff P, et al. (2003) Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology 125: 891-905.
15. Turkson J, (2004) STAT proteins as novel targets for cancer drug discovery. Expert Opin Ther Targets 8: 409-422.
16. Jaganathan S, Yue P, Turkson J, (2010) Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant signal transducer and activator of transcription 3 and epidermal growth factor receptor or Src. J Pharmacol Exp Ther 333: 373-381.
17. Turkson J, Ryan D, Kim JS, Zhang Y, Chen Z, et al. (2001) Phosphotyrosyl peptides block Stat3-mediated DNA-binding activity, gene regulation and cell transformation. J Biol Chem 276: 45443-45455.
18. Ouyang H, Mou LJ, Luk C, Liu N, Karaskova J, et al. (2000) Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol 157: 1623-1631.
19. Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, et al. (1998) Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 18: 2545-2552.
20. Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, et al. (2000) Activation of Stat3 in v-Src Transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity. J Biol Chem 275: 24935-24944.
21. Siddiquee K, Glenn M, Gunning P, Katt WP, Zhang S, et al. (2007) An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects. ACS Chem Biol 2: 787-798.
22. Lo HW, Hsu SC, Xia W, Cao X, Shih JY, et al. (2007) Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67: 9066-9076.
23. DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, et al. (2003) Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines. Oncogene 22: 7781-7795.
24. Huo L, Wang YN, Xia W, Hsu SC, Lai CC, et al. (2010) RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus. Proc Natl Acad Sci USA 107: 16125-16130.
25. Siddiquee K, Zhang S, Guida WC, Blaskovich MA, Greedy B, et al. (2007) Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. 1: Proc Natl Acad Sci U S A 104: 7391-7396.
26. Coffer PJ, Kruijer W, (1995) EGF receptor deletions define a region specifically mediating STAT transcription factor activation. Biochem Biophys Res Commun 210: 74-81.
27. Shao H, Cheng HY, Cook RG, Tweardy DJ, (2003) Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. Cancer Res 63: 3923-3930.
28. Darnell JE Jr, (1997) STATs and gene regulation. Science 277: 1630-1635.
29. Zhao W, Jaganathan S, Turkson J, (2010) A cell permeable Stat3 SH2 domain mimetic inhibits Stat3 activation and induces antitumor cell effects in vitro. J Biol Chem 2010 Aug 31. [Epub ahead of print].
30. Hsu SC, Hung MC, (2007) Characterization of a novel tripartite nuclear localization sequence in the EGFR family. J Biol Chem 282: 10432-10440.
31. Lo HW, Ali-Seyed M, Wu Y, Bartholomeusz G, Hsu SC, et al. (2006) Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. J Cell Biochem 98: 1570-1583.
32. Huo Q, (2010) Protein complexes/aggregates as potential cancer biomarker revealed by a nanoparticle aggregation immunoassay. Colloids Surf B 78: 259-265.
33. Bognadovic J, Huo Q, (2010) NanoDLSay: NanoDLSay: a new platform technology for biomolecular detection and analysis using gold nanoparticle probes coupled with dynamic light scattering. Proceedings of SPIE 7674 In press.
34. Jans H, Liu X, Austin L, Maes G, Huo Q, (2009) Dynamic light scattering as a powerful tool for gold nanoparticle bioconjugation and biomolecular binding study. Anal Chem 81: 9425-9432.
35. Liu X, Huo Q, (2009) A washing-free and amplification-free one-step homogeneous assay for protein detection using gold nanoparticle probes and dynamic light scattering. J Immunol Method 349: 38-44.
36. Liu X, Dai Q, Austin L, Coutts J, Knowles G, et al. (2008) A One-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J Am Chem Soc 130: 2780-2782.
37. Dai Q, Liu X, Coutts J, Austin L, Huo Q, (2008) A one-step highly sensitive method for DNA detection using dynamic light scattering. J Am Chem Soc 130: 8138-8139.
38. Thelemann A, Petti F, Griffin G, Iwata K, Hunt T, et al. (2005) Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells. Mol Cell Proteomics 4: 356-376.
39. Jimeno A, Tan AC, Coffa J, Rajeshkumar NV, Kulesza P, et al. (2008) Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer. Cancer Res 68: 2841-2849.
40. Turkson J, Jove R, (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19: 6613-6626.
41. Yue P, Turkson J, (2009) Targeting STAT3 in cancer: how successful are we? Expert Opin Investig Drugs 18: 45-56.
42. Grivennikov SI, Karin M, (2010) Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21: 11-19.
43. Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, et al. (2007) Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 21: 1396-1408.
44. Sinibaldi N, Wharton W, Turkson J, Bowman T, Pledger WJ, et al. (2000) Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19: 5419-5427.
45. Niu G, Wright KL, Huang M, Song L, Haura E, et al. (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21: 2000-2008.
46. Liao H-J, Carpenter G, (2007) Role of Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. Cell 18: 1064-1072.
47. Ndubuisi MI, Guo GG, Fried VA, Etlinger JD, Sehgal PB, (1999) Cellular physiology of STAT3: Where's the cytoplasmic monomer? J Biol Chem 274: 25499-25509.
48. Guo GG, Patel K, Kumar V, Shah M, Fried VA, et al. (2002) Association of the Chaperone Glucose-Regulated Protein 58 (GRP58/ER-60/ERp57) with Stat3 in Cytosol and Plasma Membrane Complexes. J Interferon Cytokine Res 22: 555-563.
49. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, et al. (1999) c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 274: 8335-8343.
50. Cao X, Tay A, Guy GR, Tan YH, (1996) Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16: 1595-1603.
51. Tice DA, Biscardi JS, Nickles AL, Parsons SJ, (1999) Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci U S A 96: 1415-1420.